Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
32.00
+1.60 (5.26%)
At close: Jun 26, 2026, 4:00 PM EDT
32.10
+0.10 (0.31%)
After-hours: Jun 26, 2026, 6:52 PM EDT
Stoke Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Stoke Therapeutics stock have an average target of 45.25, with a low estimate of 35 and a high estimate of 60. The average target predicts an increase of 41.41% from the current stock price of 32.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Stoke Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 11 | 11 | 11 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 2, 2026 |
| BTIG | BTIG | Buy Maintains $39 | Buy | Maintains | $39 | +21.88% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $50 | Buy | Maintains | $50 | +56.25% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $60 | Buy | Maintains | $60 | +87.50% | May 8, 2026 |
| Wedbush | Wedbush | Buy Maintains $38 | Buy | Maintains | $38 | +18.75% | May 8, 2026 |
Financial Forecast
Revenue This Year
26.24M
from 184.42M
Decreased by -85.77%
Revenue Next Year
46.23M
from 26.24M
Increased by 76.21%
EPS This Year
-3.25
from -0.12
EPS Next Year
-3.08
from -3.25
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 58.7M | 105.0M | |
| Avg | 26.2M | 46.2M | |
| Low | 6.2M | 6.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -68.2% | 300.2% | |
| Avg | -85.8% | 76.2% | |
| Low | -96.6% | -77.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -3.25 | -3.08 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.